We hypothesize that MGST3 acts as a modulator to regulate the interaction of α-syn with UBL3 and mediates the sorting of α-syn into small extracellular vesicles, which would provide a new idea to remove the intracellular α-syn accumulation and thus provide a treatment for synucleinopathies. This evidence concerns the gene UBL3 and synucleinopathy.